Literature DB >> 18456361

RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.

Kai Zhou1, Hongxuan He, Yanyun Wu, Mingxing Duan.   

Abstract

Avian influenza virus H5N1 causes widespread infection in the birds and human respiratory tract, but existing vaccines and drug therapy are of limited value. Here we show that small interfering RNAs (siRNAs) specific for conserved regions of the viral genome can potently inhibit influenza virus production in cell lines, embryonated chicken eggs and BALB/c mice. siRNA expression plasmid pBabe-Super was chosen in the study, which directed the synthesis of small interfering RNAs in cells. The inhibition depended on the presence of a functional antisense strand in the small interfering RNA duplex, suggesting that viral mRNA is the target of RNA interference (RNAi). Among the three small interfering RNA expression plasmids we designed, we found that small interfering RNA for nucleocapsid protein (NP) had a specific effect in inhibiting the accumulation of RNAs in infected cells because of a critical requirement for newly synthesized nucleocapsid proteins in avian influenza viral RNA transcription and replication. The findings reveal that newly synthesized nucleocapsid, polymerase A (PA) and polymerase B1 (PB1) proteins are required for avian influenza virus transcription and replication and provide a basis for the development of small interfering RNAs as prophylaxis and therapy for avian influenza infection in birds and humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456361     DOI: 10.1016/j.jbiotec.2008.03.007

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  12 in total

Review 1.  Antisense RNA: the new favorite in genetic research.

Authors:  Jian-Zhong Xu; Jun-Lan Zhang; Wei-Guo Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Oct.       Impact factor: 3.066

Review 2.  New treatments for influenza.

Authors:  Sailen Barik
Journal:  BMC Med       Date:  2012-09-13       Impact factor: 8.775

3.  A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.

Authors:  Julie Motard; Ronan Rouxel; Alexandra Paun; Veronika von Messling; Martin Bisaillon; Jean-Pierre Perreault
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

4.  Inhibiting avian influenza virus shedding using a novel RNAi antiviral vector technology: proof of concept in an avian cell model.

Authors:  Lyndsey M Linke; Jeffrey Wilusz; Kristy L Pabilonia; Johannes Fruehauf; Roberta Magnuson; Francisco Olea-Popelka; Joni Triantis; Gabriele Landolt; Mo Salman
Journal:  AMB Express       Date:  2016-02-24       Impact factor: 3.298

5.  In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery.

Authors:  Daniel Tsung-Ning Huang; Chun-Yi Lu; Pei-Lan Shao; Luan-Yin Chang; Jin-Yuan Wang; Yi-Hsuan Chang; Mei-Ju Lai; Ya-Hui Chi; Li-Min Huang
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

Review 6.  Pulmonary delivery of therapeutic siRNA.

Authors:  Jenny Ka-Wing Lam; Wanling Liang; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2011-02-26       Impact factor: 15.470

7.  Delayed Newcastle disease virus replication using RNA interference to target the nucleoprotein.

Authors:  Jessica M Hutcheson; Leonardo Susta; Steven L Stice; Claudio L Afonso; Franklin D West
Journal:  Biologicals       Date:  2015-06-04       Impact factor: 1.856

Review 8.  Insight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1.

Authors:  E M Abdelwhab; Hafez M Hafez
Journal:  Viruses       Date:  2012-11-19       Impact factor: 5.048

9.  Specific interference shRNA-expressing plasmids inhibit Hantaan virus infection in vitro and in vivo.

Authors:  Yuan-yuan Liu; Liang-jun Chen; Yan Zhong; Meng-xin Shen; Nian Ma; Bing-yu Liu; Fan Luo; Wei Hou; Zhan-qiu Yang; Hai-rong Xiong
Journal:  Acta Pharmacol Sin       Date:  2016-03-14       Impact factor: 6.150

10.  RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference.

Authors:  Julita Piasecka; Elzbieta Lenartowicz; Marta Soszynska-Jozwiak; Barbara Szutkowska; Ryszard Kierzek; Elzbieta Kierzek
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-24       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.